Most Clicked AANP SmartBrief Stories

1. Analysis finds growing ranks of NPs in U.S.

AANP SmartBrief | Jul 27, 2015

The number of nurse practitioners in the U.S. is increasing, according to an analysis of federal data. In 2013, 15% more NPs received Medicare payments than in 2012. The Courier-Journal (Louisville, Ky.) (tiered subscription model) (07/27)

2. Novel oral anticoagulant use increases among atrial fibrillation patients

AANP SmartBrief | Jul 28, 2015

A study in The American Journal of Medicine has found that the use of new direct oral anticoagulants increased significantly among patients with atrial fibrillation from 2013 to 2014. Warfarin use decreased from 2009 to 2014, according to the analysis of data from about 350,000 clinical visits per quarter. (07/22) (07/22)

3. The National Diabetes Education Program's updated online toolkit

AANP SmartBrief | Jul 29, 2015

The National Diabetes Education Program's updated online toolkit, GAME PLAN for Health Care Professionals, can help health care professionals identify, counsel, and support patients at risk for type 2 diabetes. The toolkit provides health care professionals with the information to identify prediabetes and facilitate effective intervention with their patients. To learn more, please visit Blank (07/28)

4. HHS grant to support NP residency program in N.Y.

AANP SmartBrief | Jul 30, 2015

HHS is providing a grant worth $1.65 million to the University of Rochester Medical Center's Department of Family Medicine for the development of a nurse practitioner residency program in partnership with the university's School of Nursing. The Highland Hospital program will be one of 32 to receive grants nationally. Rochester Business Journal (N.Y.) (07/29)

5. HHS launches initiative to prevent prescription drug abuse

AANP SmartBrief | Jul 31, 2015

HHS Secretary Sylvia Mathews Burwell has sought input from governors around the U.S. to craft a $100 million strategy for addressing and preventing prescription painkiller abuse. The initiative includes funding for drugs to treat overdose and addiction, and waivers for states to try innovative treatment approaches. The Hill (07/25)

6. Cholesterol drug from Regeneron, Sanofi wins FDA approval

AANP SmartBrief | Jul 27, 2015

The cholesterol-lowering drug Praluent, or alirocumab, from Regeneron Pharmaceuticals and Sanofi has been approved by the FDA for use in patients with clinical atherosclerotic cardiovascular disease and heterozygous familial hypercholesterolemia. The drug was also recommended by European regulators as a treatment for patients with high cholesterol who respond inadequately to statins. The approval from the European Commission is expected in September. Reuters (07/24)

7. AANP 2016 National Conference presentation opportunities

AANP SmartBrief | Jul 28, 2015

AANP invites all interested parties to submit proposals for 75-minute presentations, 30-minute presentations and/or poster sessions to be considered for inclusion in the AANP 2016 National Conference schedule. The deadline for submitting 75-minute presentation proposals is 5 p.m. Central Time on Aug. 5, while the deadline for 30-minute podium presentations and/or poster sessions is 5 p.m. Central Time on Aug. 26. For more information and to submit proposals, please visit the AANP 2016 National Conference presentation opportunities page. Blank (07/28)

8. Eliminating Helicobacter pylori may cut cancer risk, review finds

AANP SmartBrief | Jul 28, 2015

Study data from Asian patients showed using antibiotics to eliminate Helicobacter pylori bacteria may reduce the risk of gastric cancer in healthy individuals. The studies, which compared an antibiotic with a placebo or no treatment, did not show any differences in the risk of death from all causes. Medscape (free registration) (07/24)

9. Few diabetes patients meet all risk factor control targets

AANP SmartBrief | Jul 28, 2015

A study published in Diabetes Care revealed that only 35% of more than 5,000 diabetes patients evaluated met targets for HbA1C and LDL cholesterol levels and blood pressure, with more white than black patients meeting the targets. Researchers found 72% of patients met targets for HbA1C levels, 63% for LDL cholesterol levels and 73% for blood pressure. MedPage Today (free registration) (07/24)

10. Study: Rivastigmine leads to improved gait, fewer falls in Parkinson's disease

AANP SmartBrief | Jul 27, 2015

Parkinson's patients without dementia saw better gait variability when walking and performing a simple cognitive test after receiving rivastigmine treatment, according to a study presented at the 19th International Congress of Parkinson's Disease and Movement Disorders. The placebo-controlled study had patients keep diaries to log falls because walking gait time is a marker for fall risk, and data showed the therapy also resulted in fewer falls. Medscape (free registration) (07/22)

Sign up for AANP SmartBrief

Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more